Company Filing History:
Years Active: 2014-2015
Title: Innovations by Christopher J Bemben
Introduction
Christopher J Bemben is an accomplished inventor based in San Antonio, TX. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for exposure to acetyl cholinesterase inhibitors. With a total of three patents to his name, Bemben's work is recognized for its potential impact on public health and safety.
Latest Patents
One of Bemben's latest patents focuses on oximes for the treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors. This invention relates to non-charged oxime compounds that act as acetyl cholinesterase (AChE) reactivators. These compounds are designed to protect against organophosphate poisoning both peripherally and in the central nervous system. The patent also discloses pharmaceutical compositions and methods for preparing these reactivator compounds and their associated intermediates.
Career Highlights
Bemben is currently affiliated with the Southwest Research Institute, where he continues to innovate and develop new solutions in his field. His work has garnered attention for its relevance in addressing critical health issues related to chemical exposure.
Collaborations
Throughout his career, Bemben has collaborated with notable colleagues, including Stanton F McHardy and Richard Michael Corbett. These partnerships have contributed to the advancement of research and development in their shared areas of expertise.
Conclusion
Christopher J Bemben's contributions to the field of pharmaceuticals, particularly in the development of treatments for acetyl cholinesterase inhibitor exposure, highlight his role as a significant inventor. His innovative work continues to pave the way for advancements in public health and safety.